Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ORA.TA
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -7.29 1.12 1.20
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 14.81 16.29 14.19
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.97 38.95 38.20
Cash 3.31 3.34 3.23
Capex 38.80 -1.71 -2.80
Free Cash Flow -61.02 0.20 -0.50
Revenue -6.76 3.71 3.98
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 8.15 0.35 0.33
Operating Margin 9.65 0.23 0.21
ROA 1.97 < 0.005 < 0.005
ROE 6.32 0.02 0.02
ROIC 14.77 0.01 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ORA.TA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ORA.TA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ORA.TA is permitted for members.